表紙
市場調查報告書

數位健康·人工智能 (AI) 市場 - 趨勢,機會,預測:2020年

Digital Health & Artificial Intelligence 2020: Trends, Opportunities, and Outlook

出版商 IDTechEx Ltd. 商品編碼 930808
出版日期 內容資訊 英文 259 Slides
商品交期: 最快1-2個工作天內
價格
數位健康·人工智能 (AI) 市場 - 趨勢,機會,預測:2020年 Digital Health & Artificial Intelligence 2020: Trends, Opportunities, and Outlook
出版日期: 2020年03月24日內容資訊: 英文 259 Slides
簡介

數位健康和人工智能(AI)有望改變醫療保健的面貌。在過去的幾年中,投資的大幅增長證明了這一點,人們對數位醫療領域的興趣與日俱增。製藥,醫療技術,健康保險,零售和技術行業的主要參與者都在投資和內部產品開發方面取得了進步。

數位醫療是一個複雜的領域,其中許多技術和服務由傳統醫療環境以外的醫療服務組成。數位醫療緊隨分散醫療保健行業的全球趨勢,以減輕醫院和診所的負擔。再加上醫療保健成本的上漲,利潤率的降低以及遭受慢性病困擾的老齡化社會,數位醫療為該領域的所有參與者提供了解決方案,包括患者,供應商和付款人。實際上,數位健康為以前從未進入醫療領域並已經在該領域進行了大量投資的公司提供了誘人且有利可圖的機會。

本報告提供數位健康生態系統調查分析,提供概要,主要趨勢,機會,預測相關的系統性資訊。

目錄

第1章 摘要整理和結論

第2章 簡介

第3章 實行技術

  • 數位健康的實行技術
  • IoT
  • 5G
  • 高品質的寬頻連接
  • 人工智能與機器學習
  • VR,AR,MR

第4章 法規和安全性

  • 數位 vs. 傳統的醫療
  • 醫療設備途徑
  • 數位治療的法規
  • FDA的事前核准計劃
  • Pre-Cert 1.0
  • 數位工具等

第5章 遠端保健 (遠程醫療)

  • 遠端保健 (遠程醫療)的定義
  • 網羅廣泛的服務
  • 有很多類型
  • 主要的服務模式
  • 使用案例
  • 優點
  • 課題等

第6章 遠端患者監護

  • 遠端患者監護:檢測和應用
  • 遙控監測系統的零組件
  • 改變醫療的臉
  • 醫院·家庭
  • 家用解決方案
  • OMRON等

第7章 數位治療

  • 數位治療:應用程式為基礎的醫療
  • 數位治療 - 行動醫療的下一步?
  • 理論的根據
  • 慢性疾病
  • 追蹤和監測的遵守
  • Proteus Digital Health等

第8章 案例研究:糖尿病管理

  • 糖尿病早期引進
  • 糖尿病的成本
  • 控制副作用佔糖尿病總費用的90%
  • 糖尿病管理設備藍圖:概要
  • 大企業的策略比較
  • 血糖值測量儀的新的方向性:連接性等

第9章 消費者遺傳基因檢驗

  • Central Dogma:DNA,RNA,蛋白質
  • 什麼是DTC基因測試?
  • 遺傳的變異:什麼檢驗?
  • DTC遺傳基因檢驗的崛起
  • 基因檢驗的收益化
  • 基因學分析企業的出現等

第10章 看護者的智慧家庭

  • 隨著人口老齡化,作為照顧者的智能家居變得越來越重要
  • 智慧家庭的感測器:醫療的分散化
  • 通過安裝傳感器在家中進行醫療
  • 醫療資產的追蹤
  • 看護者生態系統的Philips的智慧家庭
  • 家庭的氣喘治療等

第11章 AI如何幫助診斷

目錄

"Digital health and AI in healthcare driven by the exponential growth of health data generation."

Digital health and artificial intelligence (AI) promises to change the face of healthcare. Reflecting this is growing interest in the digital health space, as evidenced by a substantial growth in investment over the past few years. Major players from the pharmaceutical, medtech, health insurance, retail and technology industries are all forging ahead with investments and internal product development.

Digital health is a convoluted and complex field, much of which is made up of technologies and services that enable healthcare outside of traditional clinical settings. It follows a global trend in the healthcare industry of decentralization to alleviate overburdened hospitals and clinics. Coupled with escalating healthcare costs, shrinking profit margins and ageing populations suffering with chronic conditions, digital health offers a solution to these problems for all players in the space including patients, providers and payers. In fact, it presents such an alluring and lucrative opportunity that companies not previously in the healthcare space are making significant investments and moves to do so. Big tech companies such as Amazon, Apple, Alphabet and Microsoft have continued to make significant strides into the healthcare space since their announcements in January 2018.

The time is ripe for digital health due to the combination of a number of factors. These include changing population demographics, as well as current and upcoming changes to regulations and reimbursements which mean that the route to market and take-up of digital health services and technologies is more likely. Rising capabilities in artificial intelligence, connectivity and technologies such as continuous glucose monitoring enable new forms of health communication, patient treatment and monitoring, and streamlining of healthcare services.

Telemedicine, referring to the remote delivery of healthcare services using technology, is seeing rising demand. Benefits of telemedicine include increased convenience to patients, improved quality of care, improved outcomes, and cost savings. Telemedicine and remote patient monitoring technologies enable patients to leave the hospital earlier and to stay healthy at home for longer. On the other hand, physicians benefit from the broader use of technology in telehealth, including improved communication between practitioners, access to specialists, and even remote training.

By whichever name it comes under, whether that's digiceuticals, digital therapeutics or software-as-a-drug, this idea of software replacing drugs is a worry for large, established pharmaceutical companies. Coupled with the changing landscape of healthcare which is moving away from treating patients and towards a model of preventative care and a move from fee-based to value-based services, healthcare delivery is being disrupted and digital health threatens to cause even more turbulence.

Artificial intelligence (AI) is revolutionizing medical diagnostics. The state-of-the-art results have already demonstrated that software can achieve fast and accurate image-based diagnostics on various conditions affecting the skin, eye, hear, lung, breast, and so on. These technological advancements can help automate the diagnosis and triage processes, accelerating the process to speed up the referral process especially in urgent cases, freeing up expert resources, offering the best accuracy everywhere regardless of skill levels, and making the processes more widely available. This is a ground-breaking development with far-reaching consequences. Naturally, many innovators are scrambling to capitalize on these advancements.

This report outlines the state-of-the-art in AI-based diagnosis of various conditions affecting the skin, eye, heart, breast, brain, lung, blood, genetic disorder, and so. The data sources employed are diverse including dermoscopic images, fundus images, OCT, CT, CTA, echocardiograms, electrocardiogram , mammography, pathology slides, low-res mobile phone pictures, and so on. This report then identifies and highlights companies seeking to capitalize on these technology advances to automate the diagnostic and triage process.

This report provides a detailed overview of the digital health ecosystem including insights into the key trends, opportunities and outlooks for all aspects of digital health, including:

  • Telehealth and telemedicine
  • Remote patient monitoring
  • Digital therapeutics / digiceuticals / software as a medical device
  • Diabetes management
  • Consumer genetic testing
  • Smart home as a carer
  • AI in diagnostics

Analyst access from IDTechEx

All report purchases include up to 30 minutes telephone time with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This needs to be used within three months of purchasing the report.

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY & CONCLUSIONS

  • 1.1. The Scope of Digital Health
  • 1.2. Changing Demographics Require Healthcare Reforms
  • 1.3. Factors Encouraging the Rise of Digital Health
  • 1.4. Enabling Technologies for Digital Health
  • 1.5. Effective Use of Resources Enabling Cost Efficiency
  • 1.6. The Future of Healthcare is Consumer-Led
  • 1.7. Big Tech Players are Moving into Healthcare
  • 1.8. Towards a Model of Value-Based Healthcare
  • 1.9. Big Pharma is Struggling, Disruption is Inevitable
  • 1.10. Consolidating and Collaborating to Survive and Thrive
  • 1.11. Regulation of Digital Health: Wanting the Best of Both Worlds
  • 1.12. Telehealth and Telemedicine are Poised for Take-Off
  • 1.13. The Future for Telehealth and Telemedicine
  • 1.14. Remote Patient Monitoring is Changing the Face of Healthcare
  • 1.15. The Outlook for Remote Patient Monitoring
  • 1.16. Digital Therapeutics - The Next Step for mHealth?
  • 1.17. The Outlook for Digital Therapeutics
  • 1.18. The Rise of Direct-to-Consumer Genetic Testing
  • 1.19. Sensors in Smart Homes: Decentralization of Healthcare
  • 1.20. Funding and IPOs
  • 1.21. Market Outlook: Wearable Medical Devices
  • 1.22. Outlook for Digital Health: Quality, Outcomes, and Value are Key

2. INTRODUCTION

  • 2.1. The Scope of Digital Health
  • 2.2. Digital Health Definitions
  • 2.3. Changing Demographics Require Healthcare Reforms
  • 2.4. Global Healthcare Spending is Rising
  • 2.5. Margins are Being Squeezed in Healthcare
  • 2.6. Trouble for Traditional Healthcare?
  • 2.7. Mergers and Acquisitions: Vertical Integration
  • 2.8. Big Tech Players are Moving into Healthcare
  • 2.9. Apple - 2018 Update
  • 2.10. Apple - 2019 Update
  • 2.11. Amazon
  • 2.12. Amazon - Alexa
  • 2.13. Alphabet
  • 2.14. Microsoft
  • 2.15. Tencent
  • 2.16. From Fee-for-Service to Value-Based Purchasing
  • 2.17. Towards a Model of Value-Based Healthcare
  • 2.18. Big Pharma is Struggling
  • 2.19. Digital Disruptors & Big Pharma: A Match Made in Heaven?
  • 2.20. Big Pharma: Competitions and Digital Hubs
  • 2.21. The Future for Pharma
  • 2.22. Rising Role of Venture Capital
  • 2.23. Funding and IPOs
  • 2.24. Mobile Health is Becoming the Norm
  • 2.25. Apple Enters the Electronic Health Record Market
  • 2.26. The Future of Healthcare is Consumer-Led
  • 2.27. Apps are Moving Towards Voice
  • 2.28. A Move to Precision/Personalized Medicine
  • 2.29. Biosensors are Moving to the Point-of-Care
  • 2.30. Consumer-Driven, Patient Centered Healthcare
  • 2.31. Global Challenges in Implementing Digital Health
  • 2.32. The P4 Healthcare Model
  • 2.33. The Emergence of a P4 Healthcare System
  • 2.34. Wellness and Prevention
  • 2.35. Market Outlook: Wearable Medical Devices

3. ENABLING TECHNOLOGIES

  • 3.1. Enabling Technologies for Digital Health
  • 3.2. IoT
  • 3.3. 5G
  • 3.4. Access to High Quality Broadband
  • 3.5. Artificial Intelligence and Machine Learning
  • 3.6. VR, AR and MR

4. REGULATIONS AND SECURITY

  • 4.1. Digital vs Traditional Healthcare
  • 4.2. Medical Device Pathways
  • 4.3. Regulation of Digital Therapeutics
  • 4.4. FDA Pre-Cert Program
  • 4.5. Pre-Cert 1.0
  • 4.6. Digital Tools Not Under FDA Review
  • 4.7. Regulation of Direct-to-Consumer Genetic Testing
  • 4.8. Genetic Data, Privacy Concerns and a Lack of Trust
  • 4.9. Unanswered questions about device security
  • 4.10. Security Risks for Medical Devices
  • 4.11. The Security of Data is a Critical Issue
  • 4.12. National Systems at Risk of Large-Scale Cyber Attacks

5. TELEHEALTH & TELEMEDICINE

  • 5.1. Defining Telehealth and Telemedicine
  • 5.2. Telehealth Encompasses a Range of Services
  • 5.3. There are Numerous Types of Telemedicine
  • 5.4. The Key Services Models for Telehealth
  • 5.5. Use Cases for Telehealth and Telemedicine
  • 5.6. Benefits of Telehealth and Telemedicine
  • 5.7. Challenges in Telehealth and Telemedicine
  • 5.8. Is Telehealth a Cost-Effective Solution?
  • 5.9. Telehealth and Telemedicine are Poised for Take-Off
  • 5.10. The Growing Network of Care
  • 5.11. Doctors Require Better Ways of Communication
  • 5.12. Nomadeec
  • 5.13. Smartphones Become the Tool for Doctors
  • 5.14. Driving the Uptake of Telemedicine
  • 5.15. Changes to Reimbursement of Telehealth
  • 5.16. Reimbursement of Remote Patient Monitoring
  • 5.17. Room to Improve and Mature
  • 5.18. The Next-Generation of Telemedicine
  • 5.19. Can AI Replace Your Doctor?
  • 5.20. Babylon Health
  • 5.21. TytoCare
  • 5.22. American Well
  • 5.23. Key American Well Partnerships
  • 5.24. The Future for Telehealth and Telemedicine
  • 5.25. The Future for Telehealth and Telemedicine (cont.)

6. REMOTE PATIENT MONITORING

  • 6.1. Remote Patient Monitoring: Measurements and Applications
  • 6.2. Components of a Remote Monitoring System
  • 6.3. Remote Patient Monitoring is Changing the Face of Healthcare
  • 6.4. Remote Patient Monitoring in Hospitals and the Home
  • 6.5. Remote Patient Monitoring Solutions in the Home
  • 6.6. Omron
  • 6.7. Owlet
  • 6.8. toSense
  • 6.9. Biotricity
  • 6.10. Sony
  • 6.11. Remote Patient Monitoring Solutions in Hospitals
  • 6.12. Evolution of the Stethoscope into the Digital Realm
  • 6.13. Digital Stethoscopes Enable Decentralized Healthcare
  • 6.14. The Benefits of Remote Patient Monitoring for Payers
  • 6.15. UnitedHealthcare Motion: US
  • 6.16. Momentum Multiple: South Africa
  • 6.17. Vitality: UK
  • 6.18. Vitality and Apple Watch
  • 6.19. Fitbit
  • 6.20. Elder Care
  • 6.21. Elder Care: Fall Detection
  • 6.22. Elder Care: Medical Adherence
  • 6.23. Is Remote Patient Monitoring Really Helpful?
  • 6.24. Skin Patches Emerging as a Key Form Factor
  • 6.25. Contactless/Invisible RPM
  • 6.26. Xandar Kardian
  • 6.27. The Outlook for Remote Patient Monitoring

7. DIGITAL THERAPEUTICS

  • 7.1. Digital Therapeutics: App-Based Healthcare
  • 7.2. Digital Therapeutics - The Next Step for mHealth?
  • 7.3. The Rationale Behind Digital Therapeutics (DTx)
  • 7.4. Digital Therapeutics for Chronic Conditions Poised for Success
  • 7.5. Tracking and Monitoring Adherence
  • 7.6. Proteus Digital Health
  • 7.7. Propeller Health
  • 7.8. Mental Health is a Key Focus for DTx
  • 7.9. Pear Therapeutics
  • 7.10. Carrot
  • 7.11. Akili Interactive
  • 7.12. Insurers are Investing in Digital Therapeutics
  • 7.13. Difficulties in Realising the Potential of Digital Therapeutics
  • 7.14. Digital Therapeutics Alliance
  • 7.15. Diabetes Partnerships are Proliferating
  • 7.16. The Outlook for Digital Therapeutics

8. CASE STUDY: DIABETES MANAGEMENT

  • 8.1. Diabetes is an Early Adopter of Digital Healthcare Initiatives
  • 8.2. The cost of diabetes
  • 8.3. Managing side effects accounts for 90% of the total cost of diabetes
  • 8.4. Diabetes management device roadmap: Summary
  • 8.5. Strategy comparison amongst the largest players
  • 8.6. New directions with glucometers: Connectivity
  • 8.7. The case for CGM
  • 8.8. CGM: Overview of key players
  • 8.9. Skin patches are the form factor of choice
  • 8.10. Smarter insulin delivery informing decisions
  • 8.11. Smart Pen Platform Preventing Missed Doses
  • 8.12. Smart insulin delivery device manufacturers
  • 8.13. Diabetes apps
  • 8.14. Growing ecosystem via acquisitions and partnerships
  • 8.15. Roche & mySugr
  • 8.16. Lilly & Rimidi, Lilly & Livongo
  • 8.17. Blue Mesa Health & Merck
  • 8.18. Glooko-Novo Nordisk in Diabetes Care
  • 8.19. Other case studies: Digital diabetes management
  • 8.20. BlueStar
  • 8.21. Voluntis
  • 8.22. DIABNEXT
  • 8.23. Better Therapeutics

9. CONSUMER GENETIC TESTING

  • 9.1. The Central Dogma: DNA, RNA and Proteins
  • 9.2. What is Direct-to-Consumer Genetic Testing?
  • 9.3. Genetic Variations: What Are We Testing For?
  • 9.4. The Rise of Direct-to-Consumer Genetic Testing
  • 9.5. Monetizing Genomic Testing
  • 9.6. The Emergence of Genomics Analysis Companies
  • 9.7. Not All Data is Created Equal
  • 9.8. AI Driven Genomics and Drug Development
  • 9.9. Alexa-Powered AI Genomics Platform
  • 9.10. Using Genomics to Diagnose NHS Patients
  • 9.11. AncestryDNA
  • 9.12. 23andme
  • 9.13. Foundation Medicine
  • 9.14. Atlas Biomed Group
  • 9.15. Orig3n

10. SMART HOME AS A CARER

  • 10.1. Smart Home as a Carer Becomes Increasingly Important with Ageing Populations
  • 10.2. Sensors in Smart Homes: Decentralization of Healthcare
  • 10.3. Bringing Healthcare into the Home by Fitting Sensors
  • 10.4. Medical Asset Tracking Allows for More Productive Refilling of Medicines and Vital Equipment in the Home
  • 10.5. Philips Smart Home as a Carer Ecosystem is Able to Alert Carers in Case of an Emergency
  • 10.6. Home Asthma Care
  • 10.7. Dr Alexa
  • 10.8. Health Information at Home Through Voice Technology
  • 10.9. Digital Health Apps Using Amazon Alexa
  • 10.10. 3rings
  • 10.11. Artificial intelligence in health care diagnostics: state-of-the-art and competitive landscape
  • 10.12. The rise of biomedical data
  • 10.13. Measures in deep learning(1): sensitivity and specificity
  • 10.14. Measures in deep learning(2): Area Under Curve (AUC) or area under curve of receiver operating characteristics (AUCROC).
  • 10.15. Measures in deep learning(3): Reproducibility
  • 10.16. F1-Score
  • 10.17. When AUC is not a good measure of the algorithm success?

11. HOW AI HAS HELPED IN DIAGNOSTICS

  • 11.1. 1) Skin disease: Dermoscopic melanoma recognition (2018)
  • 11.2. Dermoscopic melanoma recognition and its challenges
  • 11.3. SkinVision: a Netherland based firm to understand risk factors for skin cancer
  • 11.4. Haut AI: Using machine learning to predict effect of everything in lifestyle on skin health
  • 11.5. 2) Diagnosing diabetic retinopathy and diabetic macular edema from fundus photographs (2019)
  • 11.6. Diabetic retinopathy: features of severity and learning structure
  • 11.7. IDx: A company with $50M of funding with AI based diabetic retinopathy as the first focus
  • 11.8. 3) Google DeepMind's AI can detect over 50 sight-threatening eye conditions (2018)
  • 11.9. DeepMind: automating triage based on OCT images
  • 11.10. DeepMind: automating triage based on OCT images
  • 11.11. DeepMind: Deep learning-based mind that knows about eye diseases
  • 11.12. 4) Coronary Heart disease diagnosis (2018)
  • 11.13. 5) Determination of ejection fraction from echocardiograms (2019)
  • 11.14. Left ventricular ejection fraction assessment by deep learning procedure
  • 11.15. Caption health (Bay Labs): Deep learning on echo cardiogram creation and interpretation
  • 11.16. 6) Detection and quantification of breast densities via mammography (2018)
  • 11.17. Breast cancer screening via mammograms and pathology slides
  • 11.18. Reproducible breast cancer screening: Densitas, Kheiron Medical, and Therapixel
  • 11.19. 7) Detection of stroke, brain bleeds, and other conditions from computerized axial tomography (2018)
  • 11.20. Deep learning facilitates finding the rout cause of intracranial hemorrhage
  • 11.21. Viz ai: Brain scan deep-learning-based analysis (a physician diagnostic assistant)
  • 11.22. Brainomix: Brain imaging interpretation using deep learning
  • 11.23. 8) Deep learning of lung cancer histopathological images is able to identify cancer cells, determine their type, and predict what somatic mutations are present in the tumor (2018)
  • 11.24. Lung cancer detection made easier
  • 11.25. Optellum: early lung cancer detection
  • 11.26. 9) Facial image recognition to identify rare genetic disorders and to guide molecular diagnoses (2019)
  • 11.27. Facial image and genetic disorder: FDNA approach vs NIH (US national institute of health) approach
  • 11.28. 10) AI based time series analysis: AI applied to electrocardiograms can detect and classify arrhythmias (2019)
  • 11.29. Cardiologist-Level Arrhythmia Detection by applying AI electrocardiograms: Stanford machine learning group (2017)
  • 11.30. 11) AI based time series analysis: Detect atrial fibrillation (2018)
  • 11.31. Current health (Snap40): a band for determining who is in health risk...how does this fit?
  • 11.32. Cardiogram: accurately detecting various heart conditions with wearables
  • 11.33. 12) AI based time series analysis: Detect cardiac contractile dysfunction(2019)
  • 11.34. 12) AI based time series analysis: Detect blood chemistries linked to cardiac rhythm abnormalities
  • 11.35. Cardiologs : A French based start up to help recognize abnormal heart conditions through deep learning
  • 11.36. 14) AI based time series analysis: Detecting functional DNA sequence elements that are indicative of gene splicing (2014)
  • 11.37. Deep genomics: Cell biology manipulation as intended, powered by AI
  • 11.38. Electronic health records
  • 11.39. Natural language processing to facilitate useful healthcare record taking and big data interpretation
  • 11.40. Ubiquity of Electronic Health Records (EHRs) and learning from them
  • 11.41. Information extraction from EHRs and EHR representation learning
  • 11.42. Outcome Prediction, Computational Phenotyping, and Clinical Data De-identification from EHRs by deep learning